Cleared Traditional

K223374 - Blood Pressure Monitor

K223374 is an FDA 510(k) clearance for Blood Pressure Monitor, manufactured by Guangdong Transtek Medical Electronics Co., Ltd.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 238-day FDA review.

K223374 · Guangdong Transtek Medical Electronics Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2023
Decision
238d
Days
Class 2
Risk

K223374 is an FDA 510(k) clearance for the Blood Pressure Monitor. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Guangdong Transtek Medical Electronics Co., Ltd. (Zhongshan, CN). The FDA issued a Cleared decision on June 30, 2023 after a review of 238 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Guangdong Transtek Medical Electronics Co., Ltd. devices

FDA 510(k) Submission Details - K223374

510(k) Number K223374 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 04, 2022
Decision Date June 30, 2023
Days to Decision 238 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
113d slower than avg
Panel avg: 125d · This submission: 238d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 565
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K223374.
Electronic Blood Pressure Monitor
K230642 · Dongguan Kangweile Electronic Technology Co., Ltd. · Aug 2023
BPBIO750
K231174 · Inbody Co., Ltd. · Aug 2023
Arm Blood Pressure Monitor, models AOJ-33A and AOJ-33B
K222994 · Shenzhen AOJ Medical Technology Co., Ltd. · Jul 2023
Upper Arm Blood Pressure Monitor
K230176 · Shenzhen Yolanda Technology Co., Ltd. · Jun 2023
Microlife Upper Arm Automatic Digital Blood Pressure Monitor, Model BP3KVl-5K
K230075 · Microlife Intellectual Property GmbH · Jun 2023
Accurate 24 Non-invasive blood pressure monitor
K222658 · Accurate Meditech, Inc. · Jun 2023